Adam Crystal, Chief Medical Officer at C4 Therapeutics, Inc. (CCCC), sold 15,000 shares at $45.00 ($675K) on 2021-07-29, disclosed to the SEC on 2021-08-02.
Open-market sale of $675k CCCC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TNGX | SELL | 2026-08-05 | $736K | — | Filing → |
| TNGX | SELL | 2026-07-02 | $799K | — | Filing → |
| TNGX | SELL | 2026-06-03 | $618K | — | Filing → |